Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics
Miles D. Thompson, Takeshi Sakurai, Innocenzo Rainero, et al.
Pharmaceuticals (2017) Vol. 10, Iss. 4, pp. 79-79
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

G protein-coupled receptor (GPCR) gene variants and human genetic disease
Miles D. Thompson, Maire E. Percy, David E.C. Cole, et al.
Critical Reviews in Clinical Laboratory Sciences (2024) Vol. 61, Iss. 5, pp. 317-346
Open Access | Times Cited: 9
A Correlational Analysis of the Relationships among Intolerance of Uncertainty, Anxiety Sensitivity, Subjective Sleep Quality, and Insomnia Symptoms
Marco Lauriola, R. Nicholas Carleton, Daniela Tempesta, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 18, pp. 3253-3253
Open Access | Times Cited: 56
Insomnia in Schizophrenia Patients: Prevalence and Quality of Life
David Batalla-Martín, Ángel Gabriel Belzunegui Eraso, Eva Miralles Garijo, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 4, pp. 1350-1350
Open Access | Times Cited: 39
Orexin Signaling: A Complex, Multifaceted Process
Natasha C. Dale, Daniël Hoyer, Laura H. Jacobson, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Genetic variants of accessory proteins and G proteins in human genetic disease
Miles D. Thompson, Peter Chidiac, Pedro A. José, et al.
Critical Reviews in Clinical Laboratory Sciences (2025), pp. 1-22
Open Access
In Vitro Signaling Properties of Cannabinoid and Orexin Receptors: How Orexin Receptors Influence Cannabinoid Receptor‐Mediated Signaling
Kawthar A. Mohamed, Robert B. Laprairie
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 2
Open Access
Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Arulkumar Nagappan, Jooyeon Shin, Myeong Ho Jung
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2109-2109
Open Access | Times Cited: 41
Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity
Dina Medina‐Vera, Cristina Rosell‐Valle, Antonio J. López-Gambero, et al.
Biology (2020) Vol. 9, Iss. 11, pp. 377-377
Open Access | Times Cited: 30
Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions
Jacob M. Vigil, Sarah S. Stith, Jegason P. Diviant, et al.
Medicines (2018) Vol. 5, Iss. 3, pp. 75-75
Open Access | Times Cited: 30
Increased expression of cannabinoid CB2 and serotonin 5-HT1A heteroreceptor complexes in a model of newborn hypoxic-ischemic brain damage
Rafael Franco, Maria Pia Villa, Paula Morales, et al.
Neuropharmacology (2019) Vol. 152, pp. 58-66
Closed Access | Times Cited: 29
Pitolisant and Other Histamine-3 Receptor Antagonists—An Update on Therapeutic Potentials and Clinical Prospects
Victoria Harwell, Pius S. Fasinu
Medicines (2020) Vol. 7, Iss. 9, pp. 55-55
Open Access | Times Cited: 24
Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
Klaudia Berk, Wiktor Bzdęga, Karolina Konstantynowicz-Nowicka, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 393-393
Open Access | Times Cited: 20
Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain
Jing Lü, Manli Huang, Jinhui Li, et al.
Schizophrenia Bulletin (2021) Vol. 47, Iss. 5, pp. 1310-1319
Open Access | Times Cited: 20
When orexins meet cannabinoids: Bidirectional functional interactions
Fernando Berrendero, África Flores, Patricia Robledo
Biochemical Pharmacology (2018) Vol. 157, pp. 43-50
Open Access | Times Cited: 27
G protein-coupled receptor (GPCR) pharmacogenomics
Miles D. Thompson, David Reiner‐Link, Alessandro Berghella, et al.
Critical Reviews in Clinical Laboratory Sciences (2024) Vol. 61, Iss. 8, pp. 641-684
Open Access | Times Cited: 2
Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection
Vanlata H. Patel, Emmanouíl Karteris, Jing Chen, et al.
Clinical Science (2018) Vol. 132, Iss. 24, pp. 2547-2564
Open Access | Times Cited: 20
Factors Associated with Sleep Disorders among Methadone-Maintained Drug Users in Vietnam
Lê Anh Tuấn, Anh Duc Dang, An Ha Thi Tran, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 22, pp. 4315-4315
Open Access | Times Cited: 17
Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review
Luca Steardo, Elvira Anna Carbone, Giulia Menculini, et al.
Life (2021) Vol. 11, Iss. 3, pp. 214-214
Open Access | Times Cited: 14
The Relationship Between Eating-Attitudes and Clinical Characteristics, Agouti-Related Peptide, and Other Biochemical Markers in Adult-Attention Deficit Hyperactivity Disorder
Nilifer Gürbüzer, Hacer Akgül Ceyhun, Nurinnisa Öztürk, et al.
Journal of Attention Disorders (2023) Vol. 27, Iss. 4, pp. 394-409
Closed Access | Times Cited: 5
Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity
Jazmine D. W. Yaeger, Kevin T. Krupp, Jason J. Gale, et al.
Medicine in Drug Discovery (2020) Vol. 8, pp. 100059-100059
Open Access | Times Cited: 14
The Neural Network of Neuropeptide S (NPS): Implications in Food Intake and Gastrointestinal Functions
Luca Botticelli, Emanuela Micioni Di Bonaventura, Massimo Ubaldi, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 293-293
Open Access | Times Cited: 12
The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats
Ali Mohammad Pourrahimi, Mehdi Abbasnejad, Maryam Raoof, et al.
Peptides (2021) Vol. 146, pp. 170651-170651
Closed Access | Times Cited: 12
The preliminary investigation of orexigenic hormone gene polymorphisms on posttraumatic stress disorder symptoms
Gen Li, Kunlin Zhang, Li Wang, et al.
Psychoneuroendocrinology (2018) Vol. 100, pp. 131-136
Closed Access | Times Cited: 14
Intra-periaqueductal gray matter administration of orexin-A exaggerates pulpitis-induced anxiogenic responses and c-fos expression mainly through the interaction with orexin 1 and cannabinoid 1 receptors in rats
Ali Mohammad Pourrahimi, Mehdi Abbasnejad, Saeed Esmaeili‐Mahani, et al.
Neuropeptides (2018) Vol. 73, pp. 25-33
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top